References
- Schnipper LE, Bastian A. New frameworks to assess value of cancer care: strengths and limitations. Oncologist. 2016;21:654–658.
- Cherny NI, Sullivan R, Dafni U, et al. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). Ann Oncol. 2015;26:1547–1573.
- Cherny N. SC29.03 Value-based Assessments in Lung Cancer Therapy: the ESMO Perspective. J Thorac Oncol. 2017;12:S142–S143.
- Goldstein DA, Sarfaty M. Cancer drug pricing and reimbursement: lessons for the United States from around the world. Oncologist. 2016;21:1–3.
- Hammerman A, Greenberg D. Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders’ incentives for adopting a financial risk-sharing mechanism. Health Policy. 2009;89:78–83.
- The European Society for Medical Oncology. ESMO Magnitude of Clinical Benefit Scale Working Group. [cited 2017 May 8]. Available from: http://www.esmo.org/About-Us/Who-We-Are/Guidelines-Committee/Magnitude-of-Clinical-Benefit-Scale-Working-Group
- Ministry of Health, Israel. The Health Basket Public National Advisory Committe. (in Hebrew). [cited 2017 May 8]. Available from: https://www.health.gov.il/Services/Committee/vsal/Pages/default.aspx
- Mandelblatt JS, Ramsey SD, Lieu TA, et al. Evaluating frameworks that provide value measures for health care interventions. Value Health. 2017;20:185–192.
- Chandra A, Shafrin J, Dhawan R. Utility of cancer value frameworks for patients, payers, and physicians. Jama. 2016;315:2069–2070.
- Bentley TG, Cohen JT, Elkin EB, et al. Validity and reliability of value assessment frameworks for new cancer drugs. Value Health. 2017;20:200–205.
- Basch E. Toward a patient-centered value framework in oncology. Jama. 2016;315:2073–2074.
- Baselga J, Campone M, Piccart M, et al. Everolimus in postmenopausal hormone-receptor–positive advanced breast cancer. N Engl J Med. 2012;366:520–529.